Silence Therapeutics acquires minority stake in Arrowhead

Silence Therapeutics has acquired a stake, on-market, in Arrowhead Pharmaceuticals, Inc. of 6.01m shares, or 8.4% of the company's share capital, for a total cash consideration of $9.6m excluding transaction costs.